The Daybright Digest • March 2026

On Feb. 3, 2026, the Consolidated Appropriations Act (CAA) of 2026 was signed into law, a funding package containing significant reforms for the pharmaceutical benefit manager (PBM) industry.

Daybright Financial Expands National Presence and Launches AI-Powered Tools in First Year Under New Brand

ISELIN, N.J. — [March 5, 2026] Daybright Financial, one of the nation’s largest independent, privately held benefits and retirement planning firms, is marking the first anniversary of its brand launch following its March 2025 transition from U.S. Retirement & Benefits Partners (USRBP). The milestone caps a transformative year defined by strategic growth and innovation.

5 Employee Benefits Trends Shaping 2026

Employee benefits are undergoing a significant transformation in 2026. Rising health care costs, evolving pharmaceutical
trends, legislative changes and shifting worker expectations are reshaping employee benefits.

The Daybright Digest • January 2026

On Dec. 2, 2025, the IRS issued Notice 2025-68 announcing upcoming regulations and providing initial guidance regarding
Trump Accounts. Created by the One Big Beautiful Bill Act, Trump Accounts are a new type of tax-favored savings account for children under the age of 18.